MetLife Investment Management’s OptimizeRx OPRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $154K | Hold |
11,379
| – | – | ﹤0.01% | 2323 |
|
2025
Q1 | $98.5K | Buy |
+11,379
| New | +$98.5K | ﹤0.01% | 2534 |
|
2024
Q4 | – | Sell |
-10,083
| Closed | -$77.8K | – | 2842 |
|
2024
Q3 | $77.8K | Hold |
10,083
| – | – | ﹤0.01% | 2700 |
|
2024
Q2 | $101K | Buy |
10,083
+925
| +10% | +$9.25K | ﹤0.01% | 2600 |
|
2024
Q1 | $111K | Hold |
9,158
| – | – | ﹤0.01% | 2482 |
|
2023
Q4 | $131K | Hold |
9,158
| – | – | ﹤0.01% | 2471 |
|
2023
Q3 | $71.2K | Hold |
9,158
| – | – | ﹤0.01% | 2754 |
|
2023
Q2 | $131K | Hold |
9,158
| – | – | ﹤0.01% | 2528 |
|
2023
Q1 | $134K | Hold |
9,158
| – | – | ﹤0.01% | 2433 |
|
2022
Q4 | $154K | Hold |
9,158
| – | – | ﹤0.01% | 2402 |
|
2022
Q3 | $136K | Hold |
9,158
| – | – | ﹤0.01% | 2524 |
|
2022
Q2 | $251K | Hold |
9,158
| – | – | ﹤0.01% | 2153 |
|
2022
Q1 | $345K | Buy |
9,158
+3,371
| +58% | +$127K | ﹤0.01% | 2008 |
|
2021
Q4 | $359K | Hold |
5,787
| – | – | ﹤0.01% | 1689 |
|
2021
Q3 | $495K | Hold |
5,787
| – | – | ﹤0.01% | 1530 |
|
2021
Q2 | $358K | Hold |
5,787
| – | – | ﹤0.01% | 1778 |
|
2021
Q1 | $282K | Sell |
5,787
-2,003
| -26% | -$97.6K | ﹤0.01% | 1852 |
|
2020
Q4 | $243K | Hold |
7,790
| – | – | ﹤0.01% | 1869 |
|
2020
Q3 | $162K | Buy |
+7,790
| New | +$162K | ﹤0.01% | 1988 |
|